USPTO 2015–2025 USPTO PatentsView US Corporation

Terumo BCT, Inc.

USPTO PatentsView assignee record - 116 granted patents across 28 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

116
Total patents granted
28
CPC technology areas
12.6
Avg claims per patent
+90%
5-year filing velocity

The verdict

Terumo holds 116 US patents across 28 technology areas, rank #3,239 of 50,000 tracked assignees.

#3,239
of 50,000 US assignees by volume
Top 11%
by Innovation Score (51.4/100)
12.6
avg claims per patent
+90%
filing velocity, last 5 yrs

Portfolio overview

Terumo BCT, Inc. has been granted 116 US utility patents between 2015 and 2025, placing Terumo BCT, Inc. at rank #3,239 across all assignees tracked by PlainPatent. This portfolio spans 28 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.6 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Terumo BCT, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Terumo sits between Macau University Of Science And Technology (116 patents, rank #3,235) and Wiwynn Corporation (116 patents, rank #3,243) - the closest US assignees by grant volume. The composite Innovation Score of 51.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 76 grants, compared with 40 in the 2015–2019 window, a +90% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Terumo BCT, Inc.'s 12.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 28 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Terumo BCT, Inc. against peers pursuing similar technology classes.

Who files at Terumo's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Terumo holds 116 patents at rank #3,239, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Terumo

By rank, the assignees closest to #3,239 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Terumo's primary technology class.

Terumo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 11% higher than 89% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 12
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Terumo BCT, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 16 13.8%
2016 8 6.9%
2017 10 8.6%
2018 3 2.6%
2019 3 2.6%
2020 14 12.1%
2021 12 10.3%
2022 6 5.2%
2023 16 13.8%
2024 16 13.8%
2025 12 10.3%

Which technologies does Terumo BCT, Inc. patent most?

Top 15 of 28 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#3,239

Across all tracked assignees

Innovation Score

51.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Terumo BCT, Inc. hold?
Terumo BCT, Inc. holds 116 US granted patents filed between 2015 and 2025, spanning 28 technology areas.
What is Terumo BCT, Inc.'s Innovation Score?
Terumo BCT, Inc. has an Innovation Score of 51.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Terumo BCT, Inc. focus on?
Terumo BCT, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 51 patents. The company has filed patents in 28 CPC subclasses total.
Is Terumo BCT, Inc.'s patent filing rate increasing or decreasing?
Terumo BCT, Inc.'s recent filing velocity is +90% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Terumo BCT, Inc.'s patents?
Terumo BCT, Inc.'s patents average 12.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Terumo BCT, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Terumo's 116 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Terumo ranks #3,239 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.